Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Human Vaccines & Immunotherapeutics|April 8, 2021
Positive aspects of the mRNA platform for SARS-CoV-2 vaccinesKhalid Hajissa, Ali Mussa
BMC Research Notes|June 13, 2019
Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic testsAli Mussa, Mustafa Talib, Zeehaida Mohamed, et al.
The American Journal of the Medical Sciences|March 28, 2026
CAR T Cells Engineered Against LAG-3: Unleashing Potency in the Tumor Microenvironment of Breast CancerMohammad A I Al-Hatamleh, Mahasin Hamid, Monika Vashisht, et al.
International Journal of Pharmaceutics|November 24, 2025
Targeting cellular senescence for cancer therapyRami Abduljabbar, Yanfei Liu, Ali Mussa, et al.
Cancer Letters|June 9, 2026
Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive nicheMahasin Hamid, Alia M A Siddig, Ruaa Suliman, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive ReviewNor Hayati Ismail, Ali Mussa, Mutaz Jamal Al-Khreisat, et al.
Nutrients|July 29, 2023
The Global Prevalence of Vitamin D Deficiency and Insufficiency in Patients with Multiple Myeloma: A Systematic Review and Meta-AnalysisNor Hayati Ismail, Ali Mussa, Mutaz Jamal Al-Khreisat, et al.
Immunology|August 27, 2024
Towards understanding the role of nanomedicine in targeting TNFR2 in rheumatoid arthritisFatmawati Lambuk, Nor Asyikin Nordin, Ali Mussa, et al.
Immunological Investigations|December 14, 2023
Role of MicroRNAs in Inflammatory Joint Diseases: A ReviewNazmul Huda Syed, Ali Mussa, Abdirahman Hussein Elmi, et al.
Scientific Reports|August 1, 2020
Plasmodium falciparum isolate with histidine-rich protein 2 gene deletion from Nyala City, Western SudanMohammed A Boush, Moussa A Djibrine, Ali Mussa, et al.
Pageof 3